05/2009 - Državni zavod za intelektualno vlasništvo
12.07.2015 • Views
Share Embed Flag

05/2009 - Državni zavod za intelektualno vlasništvo

05/2009 - Državni zavod za intelektualno vlasništvo

05/2009 - Državni zavod za intelektualno vlasništvo

SHOW MORE
SHOW LESS
ePAPER READ
DOWNLOAD ePAPER
dziv.hr

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

START NOW

HR - Patenti - Hrvatski glasnik <strong>intelektualno</strong>g vlasništva 16, <strong>2009</strong>, 5, 1863 – 2065 1939(71) SmithKline Beecham Corporation, One Franklin Pla<strong>za</strong> P.O. Box7929, Philadelphia, PA 19101, US(72) DIAZ, Caroline Jean, GlaxoSmithKline c/o Corporate IntellectualProperty Dept. Five Moore Drive PO Box 13398, Research TrianglePark, NC 27709, USHAFFNER,Curt Dale, GlaxoSmithKline c/oCorporate IntellectualProperty Dept. Five Moore Drive PO Box 13398, Research TrianglePark, NC 27709, USSPEAKE, Jason Daniel, GlaxoSmithKline c/o Corporate IntellectualProperty Dept. Five Moore Drive PO Box 13398, Research TrianglePark, NC 27709, USZHANG, Cunyu, GlaxoSmithKline c/o Corporate IntellectualProperty Dept. Five Moore Drive PO Box 13398, Research TrianglePark, NC 27709, USMILLS, Wendy Yoon, GlaxoSmithKline c/o Corporate IntellectualProperty Dept. Five Moore Drive PO Box 13398, Research TrianglePark, NC 27709, USSPEARING, Paul Kenneth, GlaxoSmithKline c/o CorporateIntellectual Property Dept. Five Moore Drive PO Box 13398,Research Triangle Park, NC 27709, USCOWAN, David John, GlaxoSmithKline c/o Corporate IntellectualProperty Dept. Five Moore Drive PO Box 13398, Research TrianglePark, NC 27709, USGREEN, Gary Martin, GlaxoSmithKline c/o Corporate IntellectualProperty Dept. Five Moore Drive PO Box 13398, Research TrianglePark, NC 27709, US(51) MKPC07D 209/10 (2006.01) (97) EP 2046740 *(86) PCT/GB2007002761 20.07.2007.(96) EP 07766323.5 20.07.2007.(87) WO2008012511, 31.01.2008. 2008<strong>05</strong>(97) EP 2046740, 15.04.<strong>2009</strong>. <strong>2009</strong>16, En(31) 0614608 (32) 22.07.2006. (33) GB0624176 04.12.2006. GB(54) COMPOUNDS HAVING CRTH2 ANTAGONIST ACTIVITY(71) Oxagen Limited, 91 Milton Park, Abingdon, Oxfordshire OX14 4RY,GB(72) ARMER, Richard, Edward, Oxagen Limited 91 Milton Park,Abingdon, Oxon OX14 4RY, GBWYNNE, Graham, Michael, Summit Plc 91 Milton Park, Abingdon,Oxon OX14 4RY, GBDORGAN, Colin, Richard, Summit Plc 91 Milton Park, AbdingonOxon OX14 4RY, GBJOHNSON, Peter, David, Summit Plc 91 Milton Park, Abdingon,Oxon OX14 4RY, GB(51) MKPC07D 209/46 (2006.01) (97) EP 2049484 *A61K 31/40 (2006.01)A61K 31/4035 (2006.01)A61K 31/41 (2006.01)A61K 31/435 (2006.01)A61K 31/495 (2006.01)A61P 9/04 (2006.01)A61P 9/06 (2006.01)C07D 401/00 (2006.01)C07D 403/00 (2006.01)C07D 413/00 (2006.01)(86) PCT/SE2007000683 12.07.2007.(96) EP 07768997.4 12.07.2007.(87) WO2008008022, 17.01.2008. 200803(97) EP 2049484, 22.04.<strong>2009</strong>. <strong>2009</strong>17, En(31) 830243 P (32) 12.07.2006. (33) US913367 P 23.04.2007. US(54) ISOINDOLINE DERIVATIVES FOR THE TREATMENT OFARRHYTHMIAS(71) AstraZeneca AB, , 151 85 Södertälje, SE(72) BJÖRE, Annika, AstraZeneca R & D Mölndal, S-431 83 Mölndal,SEBOSTRÖM, Jonas, AstraZeneca R & D Mölndal, S-431 83 Mölndal,SEDAVIDSSON, Öjvind, AstraZeneca R & D Mölndal, S-431 83Mölndal, SEEMTENÄS, Hans, AstraZeneca R & D Mölndal, S-431 83 Mölndal,SEGRAN, Ulrik, AstraZeneca R & D Mölndal, S-431 83 Mölndal, SEILIEFSKI, Tommy, AstraZeneca R & D Mölndal, S-431 83 Mölndal,SEKAJANUS, Johan, AstraZeneca R & D Mölndal, S-431 83 Mölndal,SEOLSSON, Roine, AstraZeneca R & D Mölndal, S-431 83 Mölndal,SESANDBERG, Lars, AstraZeneca R & D Södertälje, S-151 85Södertälje, SESTRANDLUND, Gert, Ättehögsvägen 19, S-437 33 Lindome, SESUNDELL, Johan, AstraZeneca R & D Mölndal, S-431 83 Mölndal,SEYUAN, Zhong-Qing, AstraZeneca R & D Mölndal, S-431 83Mölndal, SE(51) MKPC07D 209/46 (2006.01) (97) EP 2<strong>05</strong>1961 *C07D 209/48 (2006.01)A61K 31/4035 (2006.01)A61P 25/00 (2006.01)(86) PCT/EP2007<strong>05</strong>8514 16.08.2007.(96) EP 07819950.2 16.08.2007.(87) WO2008020<strong>05</strong>5, 21.02.2008. 200808(97) EP 2<strong>05</strong>1961, 29.04.<strong>2009</strong>. <strong>2009</strong>18, En(31) 0616498 (32) 18.08.2006. (33) GB(54) NOVEL ISOINDOL DERIVATIVES AS EP4 RECEPTORAGONISTS(71) Glaxo Group Limited, Glaxo Wellcome House Berkeley Avenue,Greenford Middlesex UB6 0NN, GB(72) GIBLIN, Gerard Martin Paul, GlaxoSmithKline New FrontiersScience Park South Third Avenue, Harlow Essex CM19 5AW, GBHEALY, Mark Patrick, GlaxoSmithKline New Frontiers Science ParkSouth Third Avenue, Harlow Essex CM19 5AW, GBLIVERMORE, David George, GlaxoSmithKline New FrontiersScience Park South Third Avenue, Harlow Essex CM19 5AW, GBPRICE, Helen Susanne, GlaxoSmithKline New Frontiers SciencePark South Third Avenue, Harlow Essex CM19 5AW, GBSWARBRICK, Martin Edward, GlaxoSmithKline New FrontiersScience Park South Third Avenue, Harlow Essex CM19 5AW, GB(51) MKPC07D 209/64 (2006.01) (97) EP 2049485 *C07D 209/66 (2006.01)A61K 31/4015 (2006.01)A61P 25/00 (2006.01)(86) PCT/EP2007<strong>05</strong>7711 26.07.2007.(96) EP 07787935.1 26.07.2007.(87) WO2008012344, 31.01.2008. 2008<strong>05</strong>(97) EP 2049485, 22.04.<strong>2009</strong>. <strong>2009</strong>17, En(31) 0615111 (32) 28.07.2006. (33) GB(54) NAPHTHALENE DERIVATIVES USED AS EP4 RECEPTORAGONISTS(71) Glaxo Group Limited, Glaxo Wellcome House Berkeley Avenue,Greenford, Middlesex UB6 0NN, GB(72) GIBLIN, Gerard Martin Paul, GlaxoSmithKline New FrontiersScience Park South Third Avenue, Harlow Essex CM19 5AW, GBHEALY, Mark Patrick, GlaxoSmithKline New Frontiers Science ParkSouth Third Avenue, Harlow Essex CM19 5AW, GBPRICE, Helen Susanne, GlaxoSmithKline New Frontiers SciencePark South Third Avenue, Harlow Essex CM19 5AW, GB(51) MKPC07D 209/64 (2006.01) (97) EP 2046742 *C07D 209/66 (2006.01)A61P 21/00 (2006.01)(86) PCT/EP2007<strong>05</strong>7716 26.07.2007.(96) EP 07787938.5 26.07.2007.(87) WO2008012347, 31.01.2008. 2008<strong>05</strong>(97) EP 2046742, 15.04.<strong>2009</strong>. <strong>2009</strong>16, En(31) 06151<strong>05</strong> (32) 28.07.2006. (33) GB(54) BENZO [F] ISOINDOLES AS EP4 RECEPTOR AGONISTS(71) Glaxo Group Limited, Glaxo Wellcome House Berkeley Avenue,Greenford, Middlesex UB6 0NN, GB(72) GIBLIN, Gerard Martin Paul, GlaxoSmithKline New FrontiersScience Park South Third Avenue, Harlow Essex CM19 5AW, GBHEALY, Mark Patrick, GlaxoSmithKline New Frontiers Science ParkSouth Third Avenue, Harlow Essex CM19 5AW, GBPRICE, Helen Susanne, GlaxoSmithKline New Frontiers SciencePark South Third Avenue, Harlow Essex CM19 5AW, GBISSN 1331-2030

logo

products

Resources

Company

Terms of service
Privacy policy
Cookie policy
Cookie settings
Imprint
Change language
Made with love in Switzerland
© 2024 Yumpu.com all rights reserved

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!